English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

studies regarding BAE in 2014 and 2015, respectively, with To the Editor: The prevalence of obesity, defined as body 2 mass index (BMI) ≥30 kg/m , is increasing worldwide and preliminary positive treatment efficacy and safety observed. has been identified that obesity is a risk factor for several kinds of chronic diseases. According to the severity of obesity, associated coexisting chronic diseases, and functional limitations, therapies for obesity include lifestyle intervention (eg, diet and exercise), pharmacotherapy, endoscopic bariatric therapies, bariatric surgery, and bariatric embolization (BAE).

Research progress of bariatric embolization for treatment of obesity